Business as usual ended in 2013 for the U.S. medical device industry. Although it sounds dramatic, the statement is a fair one. The U.S. healthcare sector is undergoing massive change – thanks to a convergence of factors including:
- Phase-in of the Obama Administration’s new healthcare plan – The Affordable Care Act
- A new 2.3 percent federal excise tax on medical devices that took effect in January 2013
- Intense price pressure from payers – insurance companies, corporations and government
- A payer-driven shift in performance requirements - from selling devices to delivering positive patient outcomes
While these developments did not come as a surprise to the industry, they are driving medical device companies in the United States to rethink everything – including their supply chains.
We know that as a life sciences & healthcare business, you face a wide range of new - and emerging - challenges, all of which have a direct impact on your supply chain.
Expiring global patents and regulatory changes are causing uncertain demand, which creates challenges in quickly scaling up or down as customer demand fluctuates. This is why we've built PharmaShare, a shared-use supply solution where several customers share the same physical warehouse and transportation infrastructure.
DHL Supply Chain's shared-use facilities are scalable, repeatable and provide the cost efficiencies necessary to respond to a rapidly changing marketplace.
Let DHL Supply Chain provide a supply chain tailored to your needs.
Contact a Life Sciences expert today
Clinical trials are a critical part of the research and development process for new drugs. We ensure participating doctors have the right information and supplies to complete their trials.
Some products require special handling to maintain product integrity. Our cold chain solutions maintain the right temperature from the time we receive the product to the minute it arrives at its destination.